secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001193125-24-237191
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharma enters long-term supply agreement for neffy glass microvials through 2035
--------------------------------------------------------------------------------

- Upfront payment of €3 million to Nuova Ompi for glass microvial supply.
- Supplier must establish manufacturing force and capabilities to meet obligations.
- Annual minimum purchase quantities and capped annual price adjustments specified.
- Supply agreement expires December 31, 2035; termination for breach or reasonable business reasons.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/0001193125-24-237191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/d902443d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-237191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer